Daily non-political popular news in brief.

New mechanism identified for resistance to targeted lung cancer drugs

An international research team, led by investigators from the Massachusetts General Hospital Cancer Center and Dana-Farber Cancer Institute, has found a new way that some lung tumors become resistant to treatment with targeted therapy drugs like Iressa and Tarceva. Their report describes a totally new resistance mechanism that may apply to many types of cancer and suggests a treatment strategy for patients with these resistant tumors.

Read more »

Keywords: mechanism, identified, resistance, targeted, lung, cancer, drugs, drug

« Previous | Next »

Similar news on "New mechanism identified for resistance to targeted lung cancer drugs":

1. Study Reveals Mechanism For Cancer-drug Resistance
   10-11-2006 · ScienceDaily
   Using the worm Caenorhabditis elegans, researchers at UT Southwestern Medical Center have discovered a mechanism by which cancer cells become resistant to a specific class of drugs.
   Similar news · Read more »
   
2. Ireland Cancer Center researchers advance lung cancer treatment
   04-23-2007 · EurekAlert!
   Researchers at the Ireland Cancer Center of University Hospitals Case Medical Center have developed methods for treating lung cancer cells that have become resistant to new anti-cancer agents, such as Tarceva (erlotinib). Using a new second-generation of Tarceva-like medications, researchers can overcome the drug resistance, and such drugs are now in development including in clinical trials at the Ireland Cancer Center.
   Similar news · Read more »
   
3. Study reveals why certain ovarian cancers develop resistance to platinum-based chemotherapy
   02-10-2008 · EurekAlert!
   A team of researchers led by Fred Hutchinson Cancer Research Center has identified a new mechanism that explains why some recurrent ovarian tumors become resistant to treatment with commonly used platinum-based chemotherapy drugs such as cisplatin and carboplatin.
   Similar news · Read more »
   
4. MIT model could predict cells' response to drugs
   07-30-2007 · EurekAlert!
   MIT researchers have developed a model that could predict how cells will respond to targeted drug therapies. Models based on this approach could help doctors make better treatment choices and drug developers identify the ideal compound. In addition, the model could help test the effectiveness of drugs for a wide range of diseases, including cancer, arthirtis, and immune system disorders.
   Similar news · Read more »
   
5. Modeling lung cancer
   02-12-2007 · EurekAlert!
   In a new report in the February 15 issue of G&D, Dr. Martin McMahon and colleagues present a novel mouse model of non-small cell lung cancer, which will serve as a useful tool to test the efficacy of novel chemotherapeutic drug therapies in the early stages of lung tumorigenesis. Their paper provides evidence to support the use of a relatively new class of drugs, called MEK inhibitors, for lung cancer patients whose tumors contain mutations in the BRaf gene.
   Similar news · Read more »
   
6. New biomarker predicts effectiveness of breast cancer drugs
   12-07-2006 · EurekAlert!
   University of Cincinnati researchers have identified a new way to predict when anti-estrogen drug therapies are inappropriate for patients with hormone-dependent breast cancer.Scientists say these findings could help physicians more accurately predict which tumors will respond to anti-estrogen therapy and improve long-term survival for breast cancer patients.
   Similar news · Read more »
   
7. Jefferson scientists identify protein key to breast cancer spread, potential new drug target
   04-09-2007 · EurekAlert!
   Researchers at the Kimmel Cancer Center at Jefferson have identified a protein that they say is key to helping a quarter of all breast cancers spread. The finding, reported online the week of April 9, 2007, in the journal Proceedings of the National Academy of Sciences, could be a potential target for new drugs aimed at stopping or slowing the growth and progression of breast cancer.
   Similar news · Read more »
   
8. Researchers shed light on mechanism of action used by anti-cancer drug
   06-11-2007 · EurekAlert!
   Virginia Commonwealth University Massey Cancer Center researchers have uncovered a new mechanism of action of the anti-cancer drug sorafenib, which could stimulate the development of novel regimens in which it is combined with other molecularly targeted agents for patients with blood cancers and solid tumors.
   Similar news · Read more »
   
9. Penn researchers show how nanocylinders deliver medicine better than nanospheres
   04-05-2007 · EurekAlert!
   Researchers at the University of Pennsylvania School of Medicine have discovered a better way to deliver drugs to tumors. By using a cylindrical-shaped carrier they were able sustain delivery of the anticancer drug paclitaxel to an animal model of lung cancer ten times longer than that delivered on spherical-shaped carriers. These findings have implications for drug delivery as well as for better understanding cylinder-shaped viruses like Ebola and H5N1 influenza.
   Similar news · Read more »
   
10. DMP1 deletion cooperates with oncogenic K-ras in lung cancer
    10-15-2007 · EurekAlert!
    Scientists have identified the transcription factor DMP1 as a pivotal tumor suppressor for both human and mouse lung cancers, especially in carcinomas that exhibit intact Arf-p53 pathways. The research, published by Cell Press in the October 2007 issue of Cancer Cell, may lead to development of new drug therapies for lung cancer.
    Similar news · Read more »